Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
None on record since 2016.
Sits alongside
People who currently share a board or management team with this person.
- Abbas HussainMRNA
- David M. RubensteinMRNA
- Elizabeth E. TallettMRNA
- Elizabeth G. NabelMRNA
- Francois NaderMRNA
- James M. MockMRNA
- Michael R. McDonnellMRNA
- Noubar AfeyanMRNA
- Sandra HorningMRNA
- Soria Ester BanqueMRNA
- Stephane BancelMRNA
- Stephen HogeMRNA
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | MRNA | Sale | 3,471 | $139.95 | $486K |
| Jun 4, 2026 | MRNA | Sale | 3,471 | $50.00 | $174K |
| Mar 2, 2026 | MRNA | Sale | 13,885 | $52.29 | $726K |
| Dec 9, 2024 | MRNA | Sale | 529 | $44.68 | $24K |
| Dec 3, 2024 | MRNA | Sale | 112 | $43.30 | $5K |
| Nov 29, 2024 | MRNA | Sale | 1,418 | $42.79 | $61K |
| Sep 9, 2024 | MRNA | Sale | 551 | $73.57 | $41K |
| Sep 3, 2024 | MRNA | Sale | 114 | $76.99 | $9K |
| Aug 29, 2024 | MRNA | Sale | 162 | $78.03 | $13K |
| Aug 28, 2024 | MRNA | Sale | 1,319 | $79.39 | $105K |
| Jun 10, 2024 | MRNA | Sale | 5,178 | $148.09 | $767K |
| Jun 3, 2024 | MRNA | Sale | 122 | $140.72 | $17K |
| May 29, 2024 | MRNA | Sale | 183 | $144.50 | $26K |
| May 28, 2024 | MRNA | Sale | 1,296 | $162.47 | $211K |
| Mar 8, 2024 | MRNA | Sale | 544 | $99.05 | $54K |
| Mar 4, 2024 | MRNA | Sale | 117 | $94.34 | $11K |
| Feb 29, 2024 | MRNA | Sale | 670 | $94.57 | $63K |
| Dec 8, 2023 | MRNA | Sale | 563 | $79.09 | $45K |
| Dec 4, 2023 | MRNA | Sale | 111 | $79.31 | $9K |
| Sep 8, 2023 | MRNA | Sale | 557 | $107.22 | $60K |
| Sep 5, 2023 | MRNA | Sale | 115 | $111.44 | $13K |
| Jun 8, 2023 | MRNA | Sale | 565 | $124.09 | $70K |
| Jun 2, 2023 | MRNA | Sale | 110 | $130.32 | $14K |
| Mar 8, 2023 | MRNA | Sale | 561 | $141.51 | $79K |
| Mar 2, 2023 | MRNA | Sale | 459 | $136.43 | $63K |
| Dec 8, 2022 | MRNA | Sale | 490 | $179.15 | $88K |
| Sep 8, 2022 | MRNA | Sale | 478 | $137.44 | $66K |
| Jun 8, 2022 | MRNA | Sale | 1,265 | $148.12 | $187K |
SEC reporting-owner ID (CIK) 1866132 · all filings on EDGAR